These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 15328478)
1. Endothelial markers and circulating angiogenic factors and p53 may be potential markers for recurrence in surgically resected non-small cell lung cancer patients. Brattström D; Bergqvist M; Wester K; Hesselius P; Ren ZP; Scheibenpflug L; Wagenius G; Brodin O Med Sci Monit; 2004 Sep; 10(9):BR331-8. PubMed ID: 15328478 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856 [TBL] [Abstract][Full Text] [Related]
3. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology. Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354 [TBL] [Abstract][Full Text] [Related]
4. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions]. Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813 [TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer. Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915 [TBL] [Abstract][Full Text] [Related]
6. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma]. Li Q; Zhang B; Peng P Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257 [TBL] [Abstract][Full Text] [Related]
7. Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer. Lai RS; Wang JS; Hsu HK; Chang HC; Lin CH; Lin MH Jpn J Clin Oncol; 2002 Oct; 32(10):393-7. PubMed ID: 12451034 [TBL] [Abstract][Full Text] [Related]
8. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Tanaka F; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H Cancer Res; 2002 Dec; 62(23):7124-9. PubMed ID: 12460935 [TBL] [Abstract][Full Text] [Related]
9. Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery. Carbognani P; Tincani G; Crafa P; Sansebastiano G; Pazzini L; Zoni R; Bobbio A; Rusca M J Cardiovasc Surg (Torino); 2002 Aug; 43(4):545-8. PubMed ID: 12124571 [TBL] [Abstract][Full Text] [Related]
10. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307 [TBL] [Abstract][Full Text] [Related]
11. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154 [TBL] [Abstract][Full Text] [Related]